Fiduciary Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $431K | Buy |
4,971
+63
| +1% | +$6.04K | 0.04% | 229 |
|
|
2025
Q4 | $471K | Sell |
4,908
-2,778
| -36% | -$270K | 0.04% | 213 |
|
|
2025
Q3 | $732K | Sell |
7,686
-1,772
| -19% | -$163K | 0.06% | 179 |
|
|
2025
Q2 | $824K | Buy |
9,458
+107
| +1% | +$9.07K | 0.08% | 170 |
|
|
2025
Q1 | $840K | Sell |
9,351
-201
| -2% | -$18K | 0.08% | 166 |
|
|
2024
Q4 | $763K | Sell |
9,552
-433
| -4% | -$37.5K | 0.08% | 169 |
|
|
2024
Q3 | $899K | Sell |
9,985
-1,273
| -11% | -$107K | 0.09% | 155 |
|
|
2024
Q2 | $886K | Sell |
11,258
-40
| -0.4% | -$3.28K | 0.1% | 151 |
|
|
2024
Q1 | $985K | Sell |
11,298
-40
| -0.4% | -$3.41K | 0.11% | 141 |
|
|
2023
Q4 | $934K | Sell |
11,338
-7,564
| -40% | -$576K | 0.11% | 130 |
|
|
2023
Q3 | $1.48M | Sell |
18,902
-538
| -3% | -$45K | 0.19% | 98 |
|
|
2023
Q2 | $1.71M | Sell |
19,440
-985
| -5% | -$84.8K | 0.21% | 91 |
|
|
2023
Q1 | $1.65M | Sell |
20,425
-1,279
| -6% | -$104K | 0.21% | 91 |
|
|
2022
Q4 | $1.69M | Sell |
21,704
-11,803
| -35% | -$957K | 0.22% | 92 |
|
|
2022
Q3 | $2.74M | Sell |
33,507
-5,664
| -14% | -$509K | 0.36% | 68 |
|
|
2022
Q2 | $3.68M | Sell |
39,171
-5,463
| -12% | -$554K | 0.46% | 60 |
|
|
2022
Q1 | $4.49M | Sell |
44,634
-11,792
| -21% | -$1.25M | 0.59% | 47 |
|
|
2021
Q4 | $5.84M | Buy |
56,426
+635
| +1% | +$73.5K | 0.65% | 46 |
|
|
2021
Q3 | $6.92M | Buy |
55,791
+282
| +0.5% | +$36.5K | 0.79% | 42 |
|
|
2021
Q2 | $7.13M | Buy |
55,509
+1,445
| +3% | +$181K | 0.82% | 39 |
|
|
2021
Q1 | $7.08M | Buy |
54,064
+1,052
| +2% | +$123K | 0.86% | 37 |
|
|
2020
Q4 | $6.29M | Buy |
53,012
+700
| +1% | +$77.1K | 0.83% | 37 |
|
|
2020
Q3 | $5.44M | Buy |
52,312
+115
| +0.2% | +$11.5K | 0.82% | 37 |
|
|
2020
Q2 | $4.79M | Buy |
52,197
+965
| +2% | +$92.5K | 0.8% | 38 |
|
|
2020
Q1 | $4.62M | Buy |
51,232
+2,004
| +4% | +$213K | 0.91% | 35 |
|
|
2019
Q4 | $5.58M | Buy |
49,228
+877
| +2% | +$96.2K | 0.89% | 40 |
|
|
2019
Q3 | $5.25M | Buy |
48,351
+2,983
| +7% | +$311K | 0.92% | 40 |
|
|
2019
Q2 | $4.42M | Buy |
45,368
+2,240
| +5% | +$205K | 0.79% | 40 |
|
|
2019
Q1 | $3.93M | Buy |
43,128
+1,738
| +4% | +$156K | 0.73% | 43 |
|
|
2018
Q4 | $3.77M | Buy |
41,390
+2,194
| +6% | +$205K | 0.78% | 44 |
|
|
2018
Q3 | $3.86M | Buy |
39,196
+1,340
| +4% | +$124K | 0.76% | 45 |
|
|
2018
Q2 | $3.24M | Buy |
37,856
+910
| +2% | +$76K | 0.69% | 46 |
|
|
2018
Q1 | $2.96M | Buy |
36,946
+1,749
| +5% | +$144K | 0.64% | 47 |
|
|
2017
Q4 | $2.84M | Buy |
35,197
+1,248
| +4% | +$100K | 0.61% | 49 |
|
|
2017
Q3 | $2.64M | Buy |
33,949
+7,384
| +28% | +$613K | 0.59% | 52 |
|
|
2017
Q2 | $2.36M | Buy |
26,565
+8,899
| +50% | +$750K | 0.54% | 55 |
|
|
2017
Q1 | $1.42M | Buy |
+17,666
| New | +$1.38M | 0.34% | 76 |
|
Other funds holding MDT
VCM
VPM
Fiduciary Group's MDT Position: Q1 2026 in Review
Fiduciary Group increased its Medtronic (MDT) stake by 1.3% in Q1 2026, buying an estimated $6.04K and bringing the position to 4,971 shares worth $431K. The position accounts for 0.04% of the portfolio, ranked #229.
Fiduciary Group first reported a position in MDT in Q1 2017 and has held it in 37 quarters since. The position peaked at $7.13M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Fiduciary Group held 4,971 shares of Medtronic worth $431K as of Q1 2026.
- Fiduciary Group bought 63 Medtronic shares in Q1 2026, an estimated $6.04K.
- Medtronic made up 0.04% of Fiduciary Group's portfolio in Q1 2026, its #229 holding.
- Fiduciary Group first reported a position in Medtronic in Q1 2017 and has held it in 37 quarters since.
- Fiduciary Group's Medtronic position peaked at $7.13M in Q2 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.